SG Americas Securities, LLC - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 2 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$159,000
+200.0%
26,448
+80.8%
0.00%
Q3 2019$53,000
-45.4%
14,630
-59.6%
0.00%
-100.0%
Q2 2019$97,000
+32.9%
36,201
-21.7%
0.00%0.0%
Q4 2018$73,000
+25.9%
46,216
+125.6%
0.00%0.0%
Q2 2018$58,000
+28.9%
20,490
+69.3%
0.00%
Q1 2018$45,000
+40.6%
12,102
+9.4%
0.00%
Q4 2017$32,000
-83.2%
11,067
-73.8%
0.00%
-100.0%
Q3 2017$190,000
+57.0%
42,229
+59.8%
0.00%
+100.0%
Q2 2017$121,000
+28.7%
26,429
+18.6%
0.00%0.0%
Q1 2017$94,000
-58.8%
22,285
-59.7%
0.00%
-50.0%
Q4 2016$228,000
+11.8%
55,250
+109.1%
0.00%
+100.0%
Q1 2016$204,000
+16.6%
26,422
+34.0%
0.00%0.0%
Q2 2015$175,000
-1.7%
19,713
+9.3%
0.00%0.0%
Q1 2015$178,000
-54.5%
18,032
-43.5%
0.00%
-50.0%
Q4 2014$391,000
-4.9%
31,909
-22.6%
0.00%0.0%
Q3 2014$411,000
+356.7%
41,215
+50.4%
0.00%
Q1 2014$90,000
+63.6%
27,400
+49.7%
0.00%
Q3 2013$55,00018,3020.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q1 2020
NameSharesValueWeighting ↓
RA Capital Management 13,633,220$56,305,0007.98%
BVF INC/IL 2,423,300$10,008,0002.01%
EMORY UNIVERSITY 454,102$1,875,0001.85%
DAFNA Capital Management LLC 196,500$812,0000.71%
Orbimed Advisors 13,107,200$54,133,0000.69%
RTW INVESTMENTS, LP 286,285$1,182,0000.44%
Marcus Capital, LLC 100,000$413,0000.44%
Rock Springs Capital Management LP 1,375,000$5,679,0000.38%
Spark Investment Management LLC 978,600$4,041,0000.33%
Bellevue Group AG 240,000$991,0000.20%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders